FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109228518> ?p ?o ?g. }

• W2109228518 endingPage "435" @default.
• W2109228518 startingPage "427" @default.
• W2109228518 abstract "Experiments described herein were designed to evaluate the performance characteristics of a flow cytometry-based system that scores the incidence of peripheral blood micronucleated reticulocytes (MN-RETs). These procedures represent the continued refinement of a previously reported anti-CD71-based method (Dertinger et al. [1996]: Mutat Res 371:283-292), with the following modifications: incorporation of a third fluorescent label to exclude platelets from the MN-RET region, and use of a CD71-associated fluorescence thresholding technique to increase data acquisition rates. Mouse, rat, and human blood samples were analyzed using both the previously described two-color procedure (anti-CD71-FITC and propidium iodide) and a newly developed three-color technique (which adds an antiplatelet-PE antibody). The rodent specimens were also evaluated by standard microscopy procedures (acridine orange staining). Mouse blood was collected via heart puncture of vehicle- and 5-fluorouracil-treated CD-1 mice; blood samples from saline-treated Sprague-Dawley rats were collected from the tail vein and via heart puncture. Rodent blood samples were analyzed by both the two- and three-color methods. Human blood specimens, obtained via arm venipuncture from cancer patients undergoing radiation therapy, were analyzed for MN-RETs using the two-color method. Subsequently, blood samples from a single chemotherapy patient were analyzed by both the two- and three-color methods. Finally, the chemotherapy patient blood samples and blood samples from 15 healthy volunteers were evaluated at very high densities in conjunction with a CD71-associated fluorescence thresholding technique. Results of these investigations showed that data from mouse blood analyzed by the two- and three-color procedures correlated well with microscopy data (r values = 0.917 and 0.937 for the two- and three-color methods, respectively); all three methods confirmed the genotoxicity of 5-FU. Data from rat tail vein samples showed improved reproducibility with the three-color technique, but no significant difference between the two techniques was seen with the heart puncture specimens. Human blood analyzed according to the two-color procedure produced unreliable results, as platelets and platelet aggregates impacted the rare MN-RET scoring region. The three-color technique effectively overcame this problem and produced reproducible measurements that fell within expected ranges. For human blood analyses, the high cell density/CD71-thresholding technique provided significant improvements over the low-density technique, as it allowed data acquisition to occur approximately six times faster with no loss of sensitivity." @default.
• W2109228518 created "2016-06-24" @default.
• W2109228518 creator A5016976503 @default.
• W2109228518 creator A5021440089 @default.
• W2109228518 creator A5022630933 @default.
• W2109228518 creator A5028450494 @default.
• W2109228518 creator A5036645180 @default.
• W2109228518 creator A5036663495 @default.
• W2109228518 creator A5041531792 @default.
• W2109228518 creator A5043526765 @default.
• W2109228518 creator A5046702241 @default.
• W2109228518 creator A5061341462 @default.
• W2109228518 creator A5062453240 @default.
• W2109228518 creator A5084591098 @default.
• W2109228518 creator A5091336952 @default.
• W2109228518 creator A5091642263 @default.
• W2109228518 creator A5091832049 @default.
• W2109228518 creator A5030359049 @default.
• W2109228518 date "2004-01-01" @default.
• W2109228518 modified "2023-10-17" @default.
• W2109228518 title "Three-color labeling method for flow cytometric measurement of cytogenetic damage in rodent and human blood" @default.
• W2109228518 cites W1973707217 @default.
• W2109228518 cites W1992081700 @default.
• W2109228518 cites W2002798549 @default.
• W2109228518 cites W2004642777 @default.
• W2109228518 cites W2015092395 @default.
• W2109228518 cites W2025666347 @default.
• W2109228518 cites W2026363632 @default.
• W2109228518 cites W2026724232 @default.
• W2109228518 cites W2045056479 @default.
• W2109228518 cites W2047161403 @default.
• W2109228518 cites W2052373946 @default.
• W2109228518 cites W2053493344 @default.
• W2109228518 cites W2055410909 @default.
• W2109228518 cites W2066494150 @default.
• W2109228518 cites W2092740209 @default.
• W2109228518 cites W2119673466 @default.
• W2109228518 cites W2130515759 @default.
• W2109228518 cites W2132395364 @default.
• W2109228518 cites W2155439870 @default.
• W2109228518 cites W2161309067 @default.
• W2109228518 doi "https://doi.org/10.1002/em.20075" @default.
• W2109228518 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15517570" @default.
• W2109228518 hasPublicationYear "2004" @default.
• W2109228518 type Work @default.
• W2109228518 sameAs 2109228518 @default.
• W2109228518 citedByCount "72" @default.
• W2109228518 countsByYear W21092285182012 @default.
• W2109228518 countsByYear W21092285182013 @default.
• W2109228518 countsByYear W21092285182014 @default.
• W2109228518 countsByYear W21092285182015 @default.
• W2109228518 countsByYear W21092285182016 @default.
• W2109228518 countsByYear W21092285182017 @default.
• W2109228518 countsByYear W21092285182018 @default.
• W2109228518 countsByYear W21092285182019 @default.
• W2109228518 countsByYear W21092285182020 @default.
• W2109228518 countsByYear W21092285182022 @default.
• W2109228518 crossrefType "journal-article" @default.
• W2109228518 hasAuthorship W2109228518A5016976503 @default.
• W2109228518 hasAuthorship W2109228518A5021440089 @default.
• W2109228518 hasAuthorship W2109228518A5022630933 @default.
• W2109228518 hasAuthorship W2109228518A5028450494 @default.
• W2109228518 hasAuthorship W2109228518A5030359049 @default.
• W2109228518 hasAuthorship W2109228518A5036645180 @default.
• W2109228518 hasAuthorship W2109228518A5036663495 @default.
• W2109228518 hasAuthorship W2109228518A5041531792 @default.
• W2109228518 hasAuthorship W2109228518A5043526765 @default.
• W2109228518 hasAuthorship W2109228518A5046702241 @default.
• W2109228518 hasAuthorship W2109228518A5061341462 @default.
• W2109228518 hasAuthorship W2109228518A5062453240 @default.
• W2109228518 hasAuthorship W2109228518A5084591098 @default.
• W2109228518 hasAuthorship W2109228518A5091336952 @default.
• W2109228518 hasAuthorship W2109228518A5091642263 @default.
• W2109228518 hasAuthorship W2109228518A5091832049 @default.
• W2109228518 hasConcept C104317684 @default.
• W2109228518 hasConcept C105580179 @default.
• W2109228518 hasConcept C126322002 @default.
• W2109228518 hasConcept C141071460 @default.
• W2109228518 hasConcept C142724271 @default.
• W2109228518 hasConcept C153911025 @default.
• W2109228518 hasConcept C190283241 @default.
• W2109228518 hasConcept C203014093 @default.
• W2109228518 hasConcept C2775934118 @default.
• W2109228518 hasConcept C2776557347 @default.
• W2109228518 hasConcept C2778403015 @default.
• W2109228518 hasConcept C2779102032 @default.
• W2109228518 hasConcept C29730261 @default.
• W2109228518 hasConcept C31573885 @default.
• W2109228518 hasConcept C45080847 @default.
• W2109228518 hasConcept C553184892 @default.
• W2109228518 hasConcept C55493867 @default.
• W2109228518 hasConcept C71924100 @default.
• W2109228518 hasConcept C74414138 @default.
• W2109228518 hasConcept C74864618 @default.
• W2109228518 hasConcept C86803240 @default.
• W2109228518 hasConceptScore W2109228518C104317684 @default.
• W2109228518 hasConceptScore W2109228518C105580179 @default.
• W2109228518 hasConceptScore W2109228518C126322002 @default.

• next